Tailored treatment of patients with hepatocellular carcinoma with portal vein invasion: experience from a multidisciplinary hepatobiliary tumor program within a NCI comprehensive cancer center
Walcott-Sapp S, Naugler S, Lim JY, Wagner J, Orloff SL, Farsad K, Kolbeck KJ, Kaufman J, Maynard E, Enestvedt CK, Mayo SC, Billingsley KG. Tailored treatment of patients with hepatocellular carcinoma with portal vein invasion: experience from a multidisciplinary hepatobiliary tumor program within a NCI comprehensive cancer center. Journal Of Gastrointestinal Oncology 2018, 9: 1074-1083. PMID: 30603126, PMCID: PMC6286927, DOI: 10.21037/jgo.2018.08.11.Peer-Reviewed Original ResearchPortal vein invasionLiver-directed therapiesIntra-arterial brachytherapyHepatocellular carcinomaTransarterial chemoembolizationVein invasionInitial HCC diagnosisLiver-directed treatmentsMean Child-TurcotteMedian alkaline phosphataseSupportive care groupLimited treatment optionsTreatment of patientsKaplan-Meier plotsComprehensive cancer centerLog-rank methodPalliative chemotherapyChild-TurcottePugh scoreLiver dysfunctionLiver involvementVenous involvementConsecutive patientsMost patientsOverall survival